David L. Kendler

Alendronate for the Treatment of Osteoporosis in Men

Eric Orwoll, Mark P. Ettinger, Stuart Weiss et al. · New England Journal of Medicine · 2000 · 977 citations · Full text

Medicine, Pharmacoeconomics, Pharmacotherapy +11

10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension

Henry G. Bone, Rachel B. Wagman, Maria Luisa Brandi et al. · The Lancet Diabetes & Endocrinology · 2017 · 961 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +12

Intermittent Etidronate Therapy to Prevent Corticosteroid-Induced Osteoporosis

Jonathan D. Adachi, W. Bensen, Jacques P. Brown et al. · New England Journal of Medicine · 1997 · 694 citations · Full text

Medicine, Orthopaedic Surgery, Orthopedic Surgery +17

Effects of Denosumab Treatment and Discontinuation on Bone Mineral Density and Bone Turnover Markers in Postmenopausal Women with Low Bone Mass

Henry G. Bone, Michael A. Bolognese, Chui Kin Yuen et al. · The Journal of Clinical Endocrinology & Metabolism · 2011 · 611 citations

Medicine, Endocrinology, Bone Metabolism +16

Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial

David L. Kendler, Fernando Marín, Cristiano A. F. Zerbini et al. · The Lancet · 2017 · 581 citations · Full text

Medicine, Endocrinology, Gynecology +15